Tag: Neuromodulation

GTX Medical and NeuroRecovery Technologies announce merger

GTX Medical (formerly G-Therapeutics) and NeuroRecovery Technologies (NRT) have announced a merger to further the development of neuromodulation therapies to aid functional recovery of...

Immediate restoration of voluntary movement with epidural spinal cord stimulation in...

In a small cohort of patients, spinal cord stimulation has been shown to restore volitional movement in select patients with paraplegia, after intensive therapy....

CE mark approval for Stimwave’s world-first fully percutaneous spinal cord stimulator...

CE mark approval has been granted for the world’s first percutaneous injectable anchor system, SandShark. The Stimwave system is used to fixate the company’s...

Mainstay Medical ReActiv8-B clinical trial enrols first subject

The first subject has been enrolled in the ReActiv8-B Clinical Trial of the Mainstay Medical ReActiv8 device. The trial is intended to gather data...

Mainstay Medical ReActiv8-A sustains performance at one year in clinical trial

Mainstay Medical has announced the one-year results from the ReActiv8-A Clinical Trial, an international, multi-centre, prospective, single arm trial for ReActiv8 in people with...

Most patients with chronic truck or limb pain experience “substantial” pain...

Twenty-four month data from a postmarket, clinical registry have found that most patients suffering from chronic pain of the trunk and/or limbs reported “substantial”...